Health care biotech companies by dividend yield
Dividends paid over the last twelve months as a share of today's price.
Amgen leads the 20 health care biotech companies ranked by dividend yield, at 2.24%, ahead of Gilead Sciences (1.92%) and Bio-Techne (0.33%). Figures as of 19 Nov 2026, 15:48 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- First
- Amgen2.24%
- Median
- 0.00%
- Combined market value
- CHF 695.7B
- Countries
- 5
- Not ranked
- 4no dividend yield on file
Market values as of .
All countries▾
Health Care▾
Biotech▾
| # | Company | Dividend yield ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | 2.24% | CHF 199.1B | CHF 368.10 | 1.66% down | 32% up | ||
| 2 | Gilead SciencesGILD · Health Care | 1.92% | CHF 173B | CHF 139.46 | 2.13% down | 35% up | ||
| 3 | Bio-TechneTECH · Health Care | 0.33% | CHF 9.6B | CHF 61.32 | 0.04% down | 24% up | ||
| 4 | ModernaMRNA · Health Care | 0.00% | CHF 66.5B | CHF 164.24 | 1.02% down | 780% up | ||
| 5 | BiogenBIIB · Health Care | 0.00% | CHF 30.7B | CHF 207.67 | 2.04% down | 49% up | ||
| 6 | Revolution MedicinesRVMD · Health Care | 0.00% | CHF 29.7B | CHF 137.24 | 1.84% up | 129% up | ||
| 7 | Neurocrine BiosciencesNBIX · Health Care | 0.00% | CHF 13.5B | CHF 133.61 | 2.71% down | 17% up | ||
| 8 | ExelixisEXEL · Health Care | 0.00% | CHF 13.5B | CHF 55.38 | 3.82% down | 63% up | ||
| 9 | RepligenRGEN · Health Care | 0.00% | CHF 9.5B | CHF 148.51 | 2.00% up | 12% up | ||
| 10 | Halozyme TherapeuticsHALO · Health Care | 0.00% | CHF 8.8B | CHF 77.19 | 4.45% down | 39% up | ||
| 11 | Kymera TherapeuticsKYMR · Health Care | 0.00% | CHF 8.6B | CHF 100.25 | 1.85% down | 87% up | ||
| 12 | VaxcytePCVX · Health Care | 0.00% | CHF 7.9B | CHF 49.73 | 0.78% up | 23% up | ||
| 13 | Krystal BiotechKRYS · Health Care | 0.00% | CHF 7.9B | CHF 265.42 | 0.18% down | 54% up | ||
| 14 | Twist BioscienceTWST · Health Care | 0.00% | CHF 6.9B | CHF 100.66 | 2.60% up | 346% up | ||
| 15 | CG OncologyCGON · Health Care | 0.00% | CHF 6.1B | CHF 68.72 | 1.88% up | 97% up | ||
| 16 | ImmunityBioIBRX · Health Care | 0.00% | CHF 5.8B | CHF 5.46 | 3.28% down | 232% up | ||
| 17 | ImmunovantIMVT · Health Care | 0.00% | CHF 5.7B | CHF 27.68 | 1.03% down | 46% up | ||
| 18 | Kodiak SciencesKOD · Health Care | 0.00% | CHF 5.3B | CHF 81.35 | 1.37% down | 399% up | ||
| 19 | Scholar Rock HoldingSRRK · Health Care | 0.00% | CHF 5.1B | CHF 41.46 | 2.44% up | 26% up | ||
| 20 | Adaptive BiotechnologiesADPT · Health Care | 0.00% | CHF 3.9B | CHF 24.28 | 1.16% up | 74% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8432 CHF). 4 companies have no dividend yield on file and are not ranked here.
Questions and answers
Which health care biotech companies rank first by dividend yield?
Amgen (2.24%), Gilead Sciences (1.92%) and Bio-Techne (0.33%) are the top three of the 20 health care biotech companies ranked by dividend yield as of 19 Nov 2026, 15:48 UTC.
How many health care biotech companies are in this ranking?
20 are ranked by dividend yield. 4 more have no dividend yield on file and are left out rather than ranked at zero.
What are these health care biotech companies worth together?
The 20 health care biotech companies ranked by dividend yield have a combined market value of CHF 695.7B as of 19 Nov 2026, 15:48 UTC.
What does ranking by dividend yield measure?
Dividends paid over the last twelve months as a share of today's price.
Learn how this ranking works
All markets guides →- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Health care biotech companies by dividend yield”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=dividend-yield
Underlying data: Yahoo Finance; SEC EDGAR.